Does CERTOLIZUMAB PEGOL Cause Interstitial lung disease? 473 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 473 reports of Interstitial lung disease have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.5% of all adverse event reports for CERTOLIZUMAB PEGOL.
473
Reports of Interstitial lung disease with CERTOLIZUMAB PEGOL
0.5%
of all CERTOLIZUMAB PEGOL reports
37
Deaths
183
Hospitalizations
How Dangerous Is Interstitial lung disease From CERTOLIZUMAB PEGOL?
Of the 473 reports, 37 (7.8%) resulted in death, 183 (38.7%) required hospitalization, and 26 (5.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 473 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Interstitial lung disease Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX